Important Safety Information On Suboxone (buprenorphine And Naloxone) And The Risk Of Overdose Or Underdose When Switching Between Dosage Forms Or Routes Of Administration
SUBOXONE Safety Notice SUBOXONE (buprenorphine and naloxone) carries a risk of overdose or underdose when patients switch between different dosage forms or routes of administration, such as switching from tablets to films or from one delivery method to another. This risk applies to all SUBOXONE products distributed across Canada. Healthcare providers and patients using this medication should be aware that doses are not automatically equivalent across different forms of the drug.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-01-07
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/50dda748-cd5c-4df8-8555-7f53b334986f